Status:
RECRUITING
Boosting Refugee Integration Through Psychological Intervention
Lead Sponsor:
University of Zurich
Collaborating Sponsors:
ETH Zurich
The University of New South Wales
Conditions:
Psychological Distress
PTSD
Eligibility:
All Genders
16+ years
Phase:
NA
Brief Summary
Refugees and asylum seekers (RAS) face numerous stressors and adversities which put them at risk for developing mental health problems. However, access to adequate mental health care in host countries...
Detailed Description
Refugees and asylum seekers (RAS) are often exposed not only to potentially traumatic events before and during migration but also to significant post-migration stressors. Due to this combined burden, ...
Eligibility Criteria
The inclusion criteria for participating in the study are:
- refugees and asylum seekers (RAS) aged 16 or older;
- residing in one of the participating local sites (Swiss municipalities, namely, Gemeinden, and transitional asylum centers, namely, Durchgangszentren) where PM+ is offered and which gave their consent for participation in the RCT;
- speaking at least one of the following 12 languages: German, English, French, Arabic, Farsi, Kurdish, Tigrinya, Turkish, Ukrainian, Russian, Tamil, and Pashto;
- obtaining a score of 20 or higher on the Kessler Psychological Distress Scale (K10; Kessler et al., 2002), a brief clinically validated screening questionnaire that assesses general psychological distress in the past 30 days. A score equal to or higher than 20 is used as an indication of moderate to high levels of psychological distress.
The exclusion criteria for participating in the study are:
- significant cognitive or neurological impairment measured through specific tools developed by the WHO and integrated into the PM+ manual (impairment questionnaire);
- acute medical conditions or severe mental disorders (e.g., psychotic or substance-abuse disorders) measured through specific tools developed by the WHO and integrated into the PM+ manual (impairment questionnaire);
- acute risk of suicide as measured by the Suicidal Ideation Attribution Scale (SIDAS; van Spijker et al., 2014) and the Thoughts of Suicide Questionnaire (World Health Organization WHO, 2016).
Key Trial Info
Start Date :
January 14 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 20 2028
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT06776523
Start Date
January 14 2025
End Date
December 20 2028
Last Update
February 5 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Klinik für Konsiliarpsychiatrie und Psychosomatik
Zurich, Switzerland, 8091